from Pipeline to Market for
Drug discovery fast-forward in a masterly and
We manage data in an unbiased and comprehensive manner with 90% of accuracy.
Strategic partnerships that create lasting impacts.
Project-Title: Indication Prioritization using Artificial Intelligence (AI) and Machine Learning (ML).
“… Innoplexus and its proprietary Knowledge Graph called Ontosight were seen as the right partner to look for solutions for the current project.
As expected, the Innoplexus’ Indication Prioritization approach with AI & ML was able to screen a far larger number of scientific publications, exclude potential “noise“ in a much shorter period versus traditional approach, delivering as well an unbiased and reliable result-set to support prioritize indications for a selected target.
Being highly satisfied with this new approach of drug discovery, I have recommended Innoplexus to my colleagues in other teams responsible for other assets at Boehringer Ingelheim.”
– April, 2022 , Boehringer-Ingelheim
the first decentralized real-world-data exchange utility token
By leveraging AI and Blockchain technologies to empower patients over their own data and creating an ecosystem for all stakeholders in drug discovery